This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henrion, D. Articles by Levy, B. I. Search for Related Content PubMed PubMed Citation Articles by Henrion, D. Articles by Levy, B. I. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PHENYLEPHRINE

(Circulation Research. 1997;80:189-195.)
© 1997 American Heart Association, Inc.

Articles

In Vitro Modulation of a Resistance Artery Diameter by the Tissue Renin-Angiotensin System of a Large Donor Artery

Daniel Henrion, Joelle Benessiano, Bernard I. Levy

the Institut National de la Sante et de la Recherche Medicale (INSERM) Unit 141, IFR Circulation Lariboisiere, Universite Paris (France) VII.

Correspondence to D. Henrion, PhD, INSERM U 141, Hopital Lariboisiere, 41 Bd de la Chapelle, 75475 Paris, cedex 10, France. E-mail levy@infobiogen.fr

A local renin-angiotensin system (RAS) is present in the vasculature and might have an important role in the control of vascular resistance. In order to assess its functional role in the control of vasomotor tone, we investigated the effect of the RAS of a donor vessel (rat carotid artery) on the diameter of a recipient rat mesenteric resistance artery. Arteries were perfused in series in an arteriograph at a rate of 100 µL/min, under a pressure of 100 mm Hg. The two vessels were superfused in separate organ chambers to which drugs were added. Recipient artery internal diameter was measured continuously. Phenylephrine (0.1 µmol/L) was present in the organ baths throughout the experiments, ensuring a preconstriction of the recipient artery (236±4 to 174±3 µm, n=65 arterial segments from 34 rats). The angiotensin I–converting enzyme inhibitors (ACEIs) cilazapril (1 µmol/L) and captopril (10 µmol/L) inhibited phenylephrine-induced constriction by 30±12% (n=7, P<.001) and 20±8% (n=5, P<.01), respectively. Addition of cilazapril (1 µmol/L) or captopril (10 µmol/L) to the donor vessel chamber further inhibited the constriction by 8±3% (n=7, P<.01) and 31±10% (n=5, P<.05), respectively. The angiotensin II receptor (AT₁) antagonist losartan (10 µmol/L) prevented, in part, the relaxation due to the ACEI. The association of losartan (10 µmol/L) with the bradykinin B₂ receptor antagonist HOE 140 (1 µmol/L) totally prevented the relaxation due to the ACEI. Finally, angiotensin II was measured in the perfusate of the carotid artery and was found to be released at a rate of 11.9±2.2 pg in 60 minutes (n=8), which was significantly decreased to 1.4±0.4 pg in 60 minutes (n=4) by cilazapril (1 µmol/L). This study provides functional evidence that tissue-generated angiotensin II and bradykinin, produced locally and in upstream arteries, control the diameter of a resistance mesenteric artery.

Key Words: vascular reactivity • angiotensin II • angiotensin I–converting enzyme inhibitor • captopril • cilazapril

This article has been cited by other articles:

				Z. Ungvari, A. Csiszar, P. M. Kaminski, M. S. Wolin, and A. Koller Chronic High Pressure-Induced Arterial Oxidative Stress: Involvement of Protein Kinase C-Dependent NAD(P)H Oxidase and Local Renin-Angiotensin System Am. J. Pathol., July 1, 2004; 165(1): 219 - 226. [Abstract] [Full Text] [PDF]

				D. Henrion, N. Kubis, and B. I. Levy Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation Hypertension, November 1, 2001; 38(5): 1150 - 1157. [Abstract] [Full Text] [PDF]

				S. Winegrad, D. Henrion, L. Rappaport, and J. L. Samuel Self-Protection by Cardiac Myocytes Against Hypoxia and Hyperoxia Circ. Res., October 15, 1999; 85(8): 690 - 698. [Abstract] [Full Text] [PDF]

				K. Matrougui, L. Loufrani, C. Heymes, B. I. Levy, and D. Henrion Activation of AT2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance Arteries Hypertension, October 1, 1999; 34(4): 659 - 665. [Abstract] [Full Text] [PDF]

				D. Henrion, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, M. Iglarz, G. Plantefeve, D. Chatel, U. Hvass, G. Durand, J.-M. Desmonts, et al. The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro J. Am. Coll. Cardiol., September 1, 1999; 34(3): 830 - 836. [Abstract] [Full Text] [PDF]

				A. Huang, D. Sun, G. Kaley, and A. Koller Superoxide Released to High Intra-arteriolar Pressure Reduces Nitric Oxide–Mediated Shear Stress– and Agonist-Induced Dilations Circ. Res., November 2, 1998; 83(9): 960 - 965. [Abstract] [Full Text] [PDF]

				R.S. Krombach, M. J Clair, J. W Hendrick, W. V Houck, J. L Zellner, S. B Kribbs, S. Whitebread, R. Mukherjee, M. de Gasparo, and F. G Spinale Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns Cardiovasc Res, June 1, 1998; 38(3): 631 - 645. [Abstract] [Full Text] [PDF]